Correction: USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c

Ye Yao; Weijie Ma; Yonghua Guo; Yingyi Liu; Peng Xia; Xiaoling Wu; Yiran Chen; Kunlei Wang; Chengjie Mei; Ganggang Wang; Xiaomian Li; Zhonglin Zhang; Xi Chen; Yufeng Yuan

doi:10.1038/s41389-023-00470-6

Correction: USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c

Oncogenesis. 2023 May 15;12(1):27. doi: 10.1038/s41389-023-00470-6.

Authors

Ye Yao^#^{1

2}, Weijie Ma^#^{1

2}, Yonghua Guo^#^{1

2}, Yingyi Liu^{1

2}, Peng Xia^{1

2}, Xiaoling Wu^{1

2}, Yiran Chen^{1

2}, Kunlei Wang^{1

2}, Chengjie Mei^{1

2}, Ganggang Wang^{1

2}, Xiaomian Li^{1

2}, Zhonglin Zhang^{1

2}, Xi Chen^{3

4}, Yufeng Yuan^{5

6}

Affiliations

¹ Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.
² Minimally invasive treatment center of hepatobiliary and pancreatic diseases, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, P. R. China.
³ Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China. [email protected].
⁴ Minimally invasive treatment center of hepatobiliary and pancreatic diseases, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, P. R. China. [email protected].
⁵ Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China. [email protected].
⁶ Minimally invasive treatment center of hepatobiliary and pancreatic diseases, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, P. R. China. [email protected].

^# Contributed equally.

No abstract available

Publication types

Published Erratum